Robust equity market performance and an active IPO pipeline are supporting trader sentiment on 2026 listings ahead of the December 31, 2026 resolution. Through late September, 122 IPOs have priced year-to-date, generating an average 8.5% return from issue price amid a Nasdaq Composite advance of 35%. Multiple sizable deals are slated to price imminently, including Oura’s $2.1 billion offering, Accelevation Holdings’ $660 million transaction, and ADARx Pharmaceuticals’ $350 million raise, while others such as Bamboo Insurance have been postponed. Favorable conditions reflect sustained risk appetite, with institutional demand for growth-oriented issuers in AI infrastructure, biotech, and consumer hardware. Key near-term catalysts include additional September and October pricings plus any confidential filings that could accelerate timelines for high-profile names.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedDiscord IPO probability collapses amid regulatory delays and market uncertainty
Discord plunges to 11%18%
Discord's expected IPO timeline shifted from early 2026 to mid-2027 due to SEC backlog and valuation concerns, causing market probabilities for a 2026 IPO to collapse and delaying its public debut.

































Beware of external links.
Beware of external links.
Frequently Asked Questions